106
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

DEATH OBSESSION IN EGYPTIAN SAMPLES: DIFFERENCES AMONG PEOPLE WITH ANXIETY DISORDERS, SCHIZOPHRENIA, ADDICTIONS, AND NORMALS

Pages 413-424 | Published online: 11 Nov 2010
 

Abstract

Seven groups (n = 765) of Egyptian normals (non-clinical),anxiety disorder patients, and patients suffering from schizophrenia (males and females),and addicts (males only) were selected.They were generally matched as groups according to age, occupation, and education. All participants responded, indiv idually, to the Death Obsessio n Scale (DOS). Cronbach'salpha reliability statistics for the 7 groups ranged between .83 and .94, denoting from good to high internal consistency of the DOS.The most singular finding is that the female and male anxiety disorder patients'means were greatly and significantly higher than the means of the other five groups.The other salient differences were that female schizophrenics had a significantly higher mean than both male normals and male schizophrenics. Male schizophrenics and male normals had, respectively, the lowest mean DOS scores.The male addicts had a mean DOS score that was less than both male and female anxiety disorder groups. Females have higher mean DOS scores than their male counterparts in the normal, anxiety disorder patients, and patients suffering from schizophrenia groups.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.